These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results Terminated||2016-003287-39||A Phase II Open-Label Study of NUC-1031 in Patients with Platinum-Resistant Ovarian Cancer||2019-12-31||due-trials|
|Other||2019-001025-28||A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Trac...||not-yet-due|